Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cord Blood Consolidation Therapy for Elderly AML
NCT07761702Phase 3Not yet recruiting
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Oct 2026
- Primary completion
- Oct 2029
01
Overview
A Phase 3 trial of unrelated umbilical cord blood in acute myeloid leukemia (AML), sponsored by Shanghai Jiao Tong University School of Medicine. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
unrelated umbilical cord blood
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT07761702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07761702.